Hemgenix
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Hemgenix, covering 2025-07-18 to 2026-08-27. Get the full timeline:
Most recent: EMA Authorised: Hemgenix (Etranacogene dezaparvovec) — CSL Behring GmbH